期刊文献+

乐脉颗粒辅助治疗椎基底动脉供血不足95例疗效观察

Observation on Efficacy of Lemai Granules in Adjunctive Therapy of Vertebro-basilar Artery Insufficiency
下载PDF
导出
摘要 目的:观察乐脉颗粒辅助治疗椎基底动脉供血不足的疗效。方法:将186例椎基底动脉供血不足患者随机分为2组。对照组给予盐酸氟桂利嗪胶囊和血栓心脉宁胶囊;治疗组在对照组治疗基础上加服乐脉颗粒,疗程均为4wk。结果:治疗组与对照组的总有效率分别为95.8%、80.2%(P<0.01);2组治疗前、后左椎动脉、右椎动脉、基底动脉的平均血流速度差值均有统计学意义(P<0.01)。结论:乐脉颗粒辅助治疗椎基底动脉供血不足疗效确切。 OBJECTIVE: To observe the efficacy of lemai granule in adjunctive therapy of vertebro-basilar artery insufficiency, METHODS: 186 patients with vertebro- basilar artery insufficiency were randomly divided into 2 groups, lemai granule treatment group and control group.The control group were administered with flunarizine hydrochloride capsules and xueshuan xinmaining capsules, while the treatment group underwent adjunctive therapy with lemai granules besides the same treatment as the control group, the course of medication was 4 weeks in both groups.RESULTS:The total effective rates in treatment and control group were 95, 8% and 80.2% (P〈0.01), respectively, After treatment change in the average blood flow rates in left vertebral artery, right vertebral artery, and basilar artery showed statistical significance in both groups (P〈 0. 01) . CONCLUSION: Lemai granule has true curative effect in adjunctive therapy of vertebro-basilar artery insufficiency,
出处 《中国药房》 CAS CSCD 北大核心 2005年第22期1731-1732,共2页 China Pharmacy
关键词 乐脉颗粒 椎基底动脉供血不足 疗效 Lemai granule Vertebro-basilar artery insufficiency Efficacy
  • 相关文献

参考文献3

二级参考文献38

  • 1王守春,张昱.椎-基底动脉供血不足[J].中风与神经疾病杂志,1994,11(6):376-377. 被引量:60
  • 2李建章 姚淑芬.头痛头晕诊断治疗学:第1版[M].北京:中国医药科技出版社,1994.259.
  • 3[1]Kannel WB, mCGee DL.Diabetes and cardiovascular risk factors The Framingham study[J].Circulation,1979,59:8-13.
  • 4[2]Bostom AG,Gagnon DR,Cupples A, et al.Aprospective investigation of elevated lipoprotein detected by electrophoresis and cardiovascular disease in women[J].Circulation,1994,90:1688-1695.
  • 5[3]Hammnond EC, Horn D.Smoking and death rates-report on forty-four months of follow-up of 187,783 men[J].CA Cancer J Clin, 1988,38:28-58.
  • 6[4]Criqui MH,Wallace RB, Heiss G,et al. Ciiarette smoking aid plasma Hghdensity lipoprotein cholesterol:The Lipid Research Clinics Program Prevalence Study[J].Ciraalation,1980,62:1W0-76.
  • 7[5]Meade W,Imeson J, Stirling Y. Effects of chants in smoking and odiercharacteristics on clotting factors and the risk of ischaemic heart disease [J].Lancet, 1987,31:986-988.
  • 8[6]Kannel WB,Dawber TR,McGeeDL.Perspectives on systolic hypertension.The Framingham study[J].Circulation,1980,61:1179-1182.
  • 9[7]Stsmler J,Stamler R,Neaton JD. Blood presssure,Systolic and diastolic,and cradiovascular risks[J].US Population data.Arch Intem hKed,1993,153: 598-615.
  • 10[8]Reuruhnen A: Mortality in type 2 diabetes[J]. Ann Clin Res IS suppl,1983,37:26- 28.

共引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部